al Rare Diseases Research Consortium (IRDiRC), under which these new grants have been awarded, aims to accelerate research into rare diseases. Professor Paul Lasko of McGill University in Montral, Canada, Chair-Elect of the IRDiRC Executive Committee, explained: "IRDiRC's goal is to reach 200 new rare disease therapies, and diagnoses for all rare diseases, by the year 2020. To this end, it is today launching three major projects which will combine international genetic data with clinical information and data on biomaterials to help interpret the vast amounts of data the genome yields. This will aid scientists in the search for genetic causes of diseases and help identify new ways to create targeted therapies".
Professor Lochmller said: "Already we have drugs being tested in clinical trials which can, in effect, patch up the faults in the genes for some rare diseases such as Duchenne muscular dystrophy. Drugs like this are at the vanguard of a new generation of therapies that change a person's genes rather than just treating their symptoms, and they have the potential to make a real difference to the quality of life of people with the condition. By sharing data and clinical expertise in this structured way across an international network, we hope to discover similar life-changing drugs for other rare diseases."
A rare disease is defined by the European Union as one that affects fewer than five people in every 10,000 of the general population. There are between 6,000 and 8,000 known rare diseases, and approximately 30 million people across Europe are affected by a rare disease.
The four IRDiRC projects being launched in Barcelona today have received nearly 40 million EUR of funding for cutting-edge research and collaboration over the next six years. Funding focuses on international collaborations:
Page: 1 2 3 4 5 Related biology news :1
- Identifying the genetic and epigenetic causes of rare kidney disorders EURenOmics led by Heidelberg University Medical Centre, Germa
. Eliminating useless information important to learning, making new memories2
. An error-eliminating fix overcomes big problem in 3rd-gen genome sequencing3
. Immune cell death defects linked to autoimmune diseases4
. Stem cell materials could boost research into key diseases5
. The findings between DNMs and autism provides global view of mutability on human diseases6
. Transplanted genetically-modified adipose cells offer potential therapy for liver diseases7
. Removing protein garbage in nerve cells may help control 2 neurodegenerative diseases8
. Short DNA strands in the genome may be key to understanding human cognition and diseases9
. Scientists question the designation of some emerging diseases10
. Call for global monitoring of infectious diseases in dogs and cats11
. Action needed to prevent more devastating tree diseases entering the UK